Several medical societies supported extending Medicare coverage for TAVR to patients with asymptomatic aortic stenosis, but ...

Edwards pushes CMS to expand Medicare TAVR coverage to asymptomatic patients, sparking controversy among physicians over ...

NEW ORLEANS, LA—A risk model based on data from the Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Database (ACSD) ...

Pulsed-field ablation, transcatheter heart valves, and IVL are among the top stories, as they drive growth among the largest ...

Edwards Lifesciences Corporation (NYSE:EW) is one of the best healthcare stocks to buy for 2026. On January 20, Stifel raised ...

Chris Waddell, a leader for the heart valve replacement business at Abbott, announced on social media that he is leaving the company.

Edwards Lifesciences Corp. faced a legal loss early this month that forced it to call off its $945 million acquisition of ...

Medtronic plc acted on the increase in M&A and expansion of its investment ecosystem touted at the J.P. Morgan Healthcare Conference earlier this month with a $90 million infusion into Brisbane, ...

IRVINE, Calif., Jan. 29, 2026 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced the appointment of John ...

On January 9, 2026, the U.S. District Court for the District of Columbia granted the Federal Trade Commission’s request for a preliminary ...

The global structural heart devices market is experiencing robust growth, driven by increasing incidences of structural heart diseases, expanded indications for transcatheter products, and a growing ...

Edwards Lifesciences (NYSE:EW) is one of the 12 best Medical Devices stocks to invest in according to Hedge Funds. On January ...